Skip to main content
ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
15.57
+0.39 (2.57%)
At close: Feb 27, 2026, 4:00 PM EST
15.28
-0.29 (-1.86%)
After-hours: Feb 27, 2026, 7:45 PM EST

ADMA Biologics Revenue

In the year 2025, ADMA Biologics had annual revenue of $510.17M with 19.63% growth. ADMA Biologics had revenue of $139.16M in the quarter ending December 31, 2025, with 18.39% growth.

Revenue (ttm)
$510.17M
Revenue Growth
+19.63%
P/S Ratio
7.27
Revenue / Employee
$744,778
Employees
685
Market Cap
3.71B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025510.17M83.72M19.63%
Dec 31, 2024426.45M168.24M65.15%
Dec 31, 2023258.22M104.13M67.59%
Dec 31, 2022154.08M73.14M90.36%
Dec 31, 202180.94M38.72M91.72%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ACADIA Pharmaceuticals 1.07B
Legend Biotech 909.05M
Corcept Therapeutics 761.41M
Arcutis Biotherapeutics 376.07M
Ligand Pharmaceuticals 268.09M
NewAmsterdam Pharma Company 22.50M
Centessa Pharmaceuticals 15.00M
Xenon Pharmaceuticals 7.50M
Revenue Rankings

ADMA News

More News